Highline Wealth Partners’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.28K Buy
510
+214
+72% +$3.79K ﹤0.01% 725
2026
Q2
$4.74K Hold
296
– – ﹤0.01% 875
2026
Q1
$5.48K Hold
296
– – ﹤0.01% 701
2025
Q4
$4.62K Buy
296
+25
+9% +$357 ﹤0.01% 579
2025
Q3
$3.97K Hold
271
– – ﹤0.01% 642
2025
Q2
$4.19K Hold
271
– – ﹤0.01% 483
2025
Q1
$4.03K Buy
+271
New +$3.8K ﹤0.01% 475

Other funds holding TAK

Highline Wealth Partners's TAK Position: Q3 2026 in Review

Highline Wealth Partners increased its Takeda Pharmaceutical (TAK) stake by 72% in Q3 2026, buying an estimated $3.79K and bringing the position to 510 shares worth $9.28K. The position accounts for ﹤0.01% of the portfolio, ranked #725.

Highline Wealth Partners first reported a position in TAK in Q1 2025 and has held it in 7 quarters since. 366 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • Highline Wealth Partners held 510 shares of Takeda Pharmaceutical worth $9.28K as of Q3 2026.
  • Highline Wealth Partners bought 214 Takeda Pharmaceutical shares in Q3 2026, an estimated $3.79K.
  • Takeda Pharmaceutical made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #725 holding.
  • Highline Wealth Partners first reported a position in Takeda Pharmaceutical in Q1 2025 and has held it in 7 quarters since.
  • 366 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.